Meaningful changes in testosterone and estradiol could potentially be observed within the first few months of a study as body composition begins to change significantly
Eli Lilly and Company is currently researching a dual agonist called tirzepatide, which has outperformed semaglutide in phase 3 clinical trials
Only 4-7% of participants in SURMOUNT-1 and 2 discontinued the medication due to AE (Tables 2, 3)
For example, the weekly injections Wegovy and Mounjaro, which are brand names for semaglutide and tirzepatide, respectively
Diabetes (2015) 64(2):43446.10.2337/db14-0558 73 YeJHaoZMumphreyMBTownsendRLPattersonLMStylopoulosNet alGLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents
GLP-1 Users: You're Not Alone If you're taking a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, you're part of a rapidly growing community